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New CDC Opioid Prescribing Guidelines
Improving the Way Opioids are Prescribed 
for Safer Chronic Pain Treatment
Almost 2 million Americans, age 12 or older, 
either abused or were dependent on opioid 
pain relievers in 2013.5 
The problem:
Existing guidelines vary in recommendations, and primary care providers say they receive insufficient 
training in prescribing opioid pain relievers. It is important that patients receive appropriate pain 
treatment, and that the benefits and risks of treatment options are carefully considered.
In 2012, health care providers wrote 259 
million prescriptions for opioid pain relievers 
– enough for every American adult to have a 
bottle of pills 1
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In 2013, more than 16,000 people died in 
the United States from overdose related to 
opioid pain relievers, four times the number 
in 1999.6 
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Improving practice:
Improving the way opioids are prescribed through clinical practice guidelines can ensure patients 
have access to safer, more effective chronic pain treatment while reducing the number of people who 
misuse, abuse, or overdose from these powerful drugs.
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Prescription opioid sales in the United States have 
increased by 300% since 19992, but there has not 
been an overall change in the amount of pain 
Americans report3,4.
Guidelines Development: Methods and Processes 
CDC used the Grading of Recommendations Assessment, Development, and Evaluation method to guidelines development 
(www.gradeworkinggroup.org). This method uses a transparent approach to grading quality of evidence and strength of 
recommendations. Four factors were used to determine the recommendations: 1) quality of evidence, 2) balance between 
benefits and harms, 3) values and preferences, and 4) costs. CDC also has developed a tiered approach to involve 
stakeholders in guidelines development.
Core Expert Group
The Core Expert Group includes CDC scientific staff, 
professional society representatives, subject matter 
experts, state agency representatives, and an expert 
in guidelines development methodology. This group 
reviews the evidence and consults on CDC-drafted 
recommendations.
Stakeholder Review Group
The Stakeholder Review Group includes a larger 
group of interested stakeholders that reviews the 
draft of CDC guidelines to improve the specificity 
and applicability of the recommendations. This 
group includes representation from professional 
medical organizations, community groups, and other 
organizations with an interest in pain management.
Peer Review and Public Comment
CDC has invited subject matter experts and the 
public to provide an independent review of the 
recommendations to ensure scientific quality and 
reasonableness of the recommendations.
Federal Partner Review
Interagency collaboration is critical for translation of 
these recommendations into practice. Federal partners 
were asked to review the guidelines and identify 
venues for dissemination and implementation.
New Prescribing Guidelines 
The Centers for Disease Control and Prevention (CDC) is 
publishing new opioid prescribing guidelines for chronic 
pain. The agency is working for timely release of the 
guidelines while ensuring that the development process: 
• Meets scientific standards
• Includes expert consultation
• Allows for appropriate stakeholders to provide input 
• Facilitates partnership development to enhance 
dissemination and uptake
Intended Purpose and Use of Guidelines
The purpose of the CDC guidelines is to provide 
recommendations for the prescribing of opioid pain 
relievers for patients 18 and older in primary care settings. 
Recommendations focus on the use of opioids in treating 
chronic pain (i.e., pain lasting longer than 3 months or past the 
time of normal tissue healing) outside end-of-life care. 
Clinical practices addressed in the guidelines:
• Determining when to initiate or continue opioids for chronic 
pain outside end-of-life care
• Opioid selection, dosage, duration, follow-up, and 
discontinuation
• Assessing risk and addressing harms of opioid use
